ELECTROPHYSIOLOGIC ACTIONS OF O-DEMETHYL ENCAINIDE - AN ACTIVE METABOLITE

[11] THE EFFECT OF QUINIDINE AND ITS METABOLITES ON THE ELECTROCARDIOGRAM AND SYSTOLIC-TIME INTERVALS - CONCENTRATION - EFFECT RELATIONSHIPS [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (02) : 187 - 195

[12] ELECTROPHYSIOLOGY OF ORAL ENCAINIDE [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (05) : 1270 - 1278

[13] METABOLITE CUMULATION DURING LONG-TERM ORAL ENCAINIDE ADMINISTRATION [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (04) : 427 - 432

[14] CLINICAL-EXPERIENCE OF ENCAINIDE (MJ-9067) - NEW ANTI-ARRHYTHMIC DRUG [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (05) : 323 - 326

[15] ANTI-ARRHYTHMIC EFFICACY OF ENCAINIDE IN PATIENTS WITH REFRACTORY RECURRENT VENTRICULAR-TACHYCARDIA [J]. CIRCULATION, 1981, 63 (03) : 670 - 675

[16] ANALYSIS OF ENCAINIDE IN PLASMA BY RADIOIMMUNOASSAY AND HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J]. THERAPEUTIC DRUG MONITORING, 1979, 1 (04) : 507 - 524

[17] OATES JA, 1973, BIOL EFFECTS DRUGS R

[18] FURTHER IMPROVED METHOD FOR MEASURING MONOPHASIC ACTION POTENTIALS OF INTACT HUMAN HEART [J]. JOURNAL OF ELECTROCARDIOLOGY, 1971, 4 (01) : 19 - +

[19] TOTAL SUPPRESSION OF VENTRICULAR ARRHYTHMIAS BY ENCAINIDE - PHARMACOKINETIC AND ELECTROCARDIOGRAPHIC CHARACTERISTICS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (16) : 877 - 882

[20] RODEN DM, 1982, J PHARM EXP THER, V221, P522

[11] THE EFFECT OF QUINIDINE AND ITS METABOLITES ON THE ELECTROCARDIOGRAM AND SYSTOLIC-TIME INTERVALS - CONCENTRATION - EFFECT RELATIONSHIPS [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (02) : 187 - 195

[12] ELECTROPHYSIOLOGY OF ORAL ENCAINIDE [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (05) : 1270 - 1278

[13] METABOLITE CUMULATION DURING LONG-TERM ORAL ENCAINIDE ADMINISTRATION [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (04) : 427 - 432

[14] CLINICAL-EXPERIENCE OF ENCAINIDE (MJ-9067) - NEW ANTI-ARRHYTHMIC DRUG [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (05) : 323 - 326

[15] ANTI-ARRHYTHMIC EFFICACY OF ENCAINIDE IN PATIENTS WITH REFRACTORY RECURRENT VENTRICULAR-TACHYCARDIA [J]. CIRCULATION, 1981, 63 (03) : 670 - 675

[16] ANALYSIS OF ENCAINIDE IN PLASMA BY RADIOIMMUNOASSAY AND HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J]. THERAPEUTIC DRUG MONITORING, 1979, 1 (04) : 507 - 524

[17] OATES JA, 1973, BIOL EFFECTS DRUGS R

[18] FURTHER IMPROVED METHOD FOR MEASURING MONOPHASIC ACTION POTENTIALS OF INTACT HUMAN HEART [J]. JOURNAL OF ELECTROCARDIOLOGY, 1971, 4 (01) : 19 - +

[19] TOTAL SUPPRESSION OF VENTRICULAR ARRHYTHMIAS BY ENCAINIDE - PHARMACOKINETIC AND ELECTROCARDIOGRAPHIC CHARACTERISTICS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (16) : 877 - 882

[20] RODEN DM, 1982, J PHARM EXP THER, V221, P522